Evotec and Bristol Myers Squibb advance neuroscience partnership - PharmaTimes $25m milestone payment supports pipeline progress in neurodegenerative disease research

#pharmaceuticals #drugdiscovery #drugdevelopment #Evotec #BristolMyersSquibb #BMS #neuroscience #neurodegenerativediseaseresearch #EvotecSE #preclinicalpipeline #neurodegenerativediseases #diseasemodifyingtreatments #phase1clinicaltrials #neurodegenerativeconditions
zurl.co/I4VyR